Silvercrest Asset Management’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$420K Buy
1,901
+97
+5% +$26.8K ﹤0.01% 721
2026
Q1
$533K Sell
1,804
-1,585
-47% -$471K ﹤0.01% 680
2025
Q4
$925K Sell
3,389
-509
-13% -$138K 0.01% 622
2025
Q3
$1.05M Sell
3,898
-108
-3% -$29.4K 0.01% 607
2025
Q2
$1.1M Buy
4,006
+128
+3% +$34.8K 0.01% 620
2025
Q1
$1.03M Buy
+3,878
New +$957K 0.01% 619

Other funds holding CME

Silvercrest Asset Management's CME Position: Q2 2026 in Review

Silvercrest Asset Management increased its CME Group (CME) stake by 5.4% in Q2 2026, buying an estimated $26.8K and bringing the position to 1,901 shares worth $420K. The position accounts for ﹤0.01% of the portfolio, ranked #721.

Silvercrest Asset Management first reported a position in CME in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.1M in Q2 2025. 1,698 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Silvercrest Asset Management held 1,901 shares of CME Group worth $420K as of Q2 2026.
  • Silvercrest Asset Management bought 97 CME Group shares in Q2 2026, an estimated $26.8K.
  • CME Group made up ﹤0.01% of Silvercrest Asset Management's portfolio in Q2 2026, its #721 holding.
  • Silvercrest Asset Management first reported a position in CME Group in Q1 2025 and has held it in 6 quarters since.
  • Silvercrest Asset Management's CME Group position peaked at $1.1M in Q2 2025.
  • 1,698 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Silvercrest Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.